Published in Hum Pathol on November 01, 1996
Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol (2000) 2.40
Galectin-3 and metastasis. Glycoconj J (2004) 1.84
90K (Mac-2 BP) and galectins in tumor progression and metastasis. Glycoconj J (2004) 1.33
Expression of galectins in cancer: a critical review. Glycoconj J (2004) 1.28
A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics. Acta Histochem (2010) 1.27
The role of galectin-3 in cancer drug resistance. Drug Resist Updat (2007) 1.23
Regulation of prostate cancer progression by galectin-3. Am J Pathol (2009) 1.21
Galectins as cancer biomarkers. Cancers (Basel) (2010) 1.08
Galectin-1: a bifunctional regulator of cellular proliferation. Glycoconj J (2004) 1.08
Multiple functions of the 37/67-kd laminin receptor make it a suitable target for novel cancer gene therapy. Mol Ther (2009) 1.03
Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness. Mol Med (2009) 0.97
Chemical inhibition of prometastatic lysyl-tRNA synthetase-laminin receptor interaction. Nat Chem Biol (2013) 0.92
Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy. Cancer Immunol Immunother (2014) 0.92
Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity. Cancer Res (2014) 0.91
Comprehensive analysis of cellular galectin-3 reveals no consistent oncogenic function in pancreatic cancer cells. PLoS One (2011) 0.88
Structure-guided identification of a laminin binding site on the laminin receptor precursor. J Mol Biol (2010) 0.87
Changes in the expression and subcellular distribution of galectin-3 in clear cell renal cell carcinoma. J Exp Clin Cancer Res (2011) 0.85
KSHV downregulation of galectin-3 in Kaposi's sarcoma. Glycobiology (2009) 0.85
Why anti-Bcl-2 clinical trials fail: a solution. Cancer Metastasis Rev (2014) 0.84
Modified apple polysaccharide prevents against tumorigenesis in a mouse model of colitis-associated colon cancer: role of galectin-3 and apoptosis in cancer prevention. Eur J Nutr (2011) 0.81
Galectin-3 induces clustering of CD147 and integrin-β1 transmembrane glycoprotein receptors on the RPE cell surface. PLoS One (2013) 0.81
Expression of Galectins 1, 3 and 9 in normal oral epithelium, oral squamous papilloma, and oral squamous cell carcinoma. Dent Res J (Isfahan) (2014) 0.79
Decreased galectin-3 expression during the progression of cervical neoplasia. J Cancer Res Clin Oncol (2005) 0.79
Toward functional glycomics by localization of tissue lectins: immunohistochemical galectin fingerprinting during diethylstilbestrol-induced kidney tumorigenesis in male Syrian hamster. Histochem Cell Biol (2004) 0.77
Galectin-3 expression: a useful tool in the differential diagnosis of posterior fossa tumors in children. Childs Nerv Syst (2010) 0.77
Clinicopathological significance of decreased galectin-3 expression and the long-term prognosis in patients with breast cancer. Surg Today (2012) 0.77
Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia. J Pathol Transl Med (2015) 0.76
Expression of immune checkpoint molecules in endometrial carcinoma. Exp Ther Med (2015) 0.75
Differential expression of renal proteins in a rodent model of Meckel syndrome. Nephron Exp Nephrol (2010) 0.75
The Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1. Int J Mol Sci (2016) 0.75
Immunohistochemical clue for the histological overlap of salivary adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. Interv Med Appl Sci (2013) 0.75
Immunohistochemical Studies on Galectin Expression in Colectomised Patients with Ulcerative Colitis. Biomed Res Int (2016) 0.75
SKY analysis revealed recurrent numerical and structural chromosome changes in BDII rat endometrial carcinomas. Cancer Cell Int (2011) 0.75
Pigment epithelium-derived factor promotes tumor metastasis through an interaction with laminin receptor in hepatocellular carcinomas. Cell Death Dis (2017) 0.75
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med (1983) 8.82
The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet (1992) 8.20
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med (1996) 7.09
Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest (1981) 6.89
Human gene mutation database-a biomedical information and research resource. Hum Mutat (2000) 6.87
Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J Immunol (1980) 6.69
Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst (1988) 5.42
New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates. Biochemistry (1979) 5.02
Structure of the promoter for chicken alpha 2 type I collagen gene. Proc Natl Acad Sci U S A (1981) 4.89
An estimate of unique DNA sequence heterozygosity in the human genome. Hum Genet (1985) 4.75
Chemical synthesis of a polypeptide predicted from nucleotide sequence allows detection of a new retroviral gene product. Nature (1980) 4.35
Galectins. Structure and function of a large family of animal lectins. J Biol Chem (1994) 4.29
Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc Natl Acad Sci U S A (1981) 4.26
The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod (1989) 4.13
Galectins: a family of animal beta-galactoside-binding lectins. Cell (1994) 3.99
Levels of translatable mRNAs for cell surface protein, collagen precursors, and two membrane proteins are altered in Rous sarcoma virus-transformed chick embryo fibroblasts. Proc Natl Acad Sci U S A (1977) 3.80
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci U S A (2000) 3.61
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst (1996) 3.53
Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum Genet (1991) 3.48
Neighboring-nucleotide effects on the rates of germ-line single-base-pair substitution in human genes. Am J Hum Genet (1998) 3.12
BRCA2 mutations in primary breast and ovarian cancers. Nat Genet (1996) 2.91
Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol (1983) 2.90
PTEN/MMAC1 mutations in endometrial cancers. Cancer Res (1997) 2.89
Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci U S A (1996) 2.85
DNA restriction fragment length polymorphisms and heterozygosity in the human genome. Hum Genet (1984) 2.79
The human gene mutation database. Trends Genet (1997) 2.72
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers. Cancer (1995) 2.64
Unmethylated domains in vertebrate DNA. Nucleic Acids Res (1983) 2.58
Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature (1994) 2.53
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene (2008) 2.47
Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet Gynecol (1992) 2.43
Isolation and partial characterization of the entire human pro alpha 1(II) collagen gene. Nucleic Acids Res (1985) 2.42
Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol (2000) 2.40
Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res (1989) 2.39
Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene. Hum Genet (1997) 2.37
Human Gene Mutation Database: towards a comprehensive central mutation database. J Med Genet (2008) 2.37
Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. Am J Clin Pathol (1983) 2.33
Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst (1997) 2.30
Regional mapping of six cloned DNA sequences on human chromosome 7. Am J Hum Genet (1986) 2.26
Report of the DNA committee and catalogues of cloned and mapped genes and DNA polymorphisms. Cytogenet Cell Genet (1990) 2.21
Genetic instability of microsatellites in endometrial carcinoma. Cancer Res (1993) 2.20
Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res (1991) 2.20
BCG and cancer (first of two parts). N Engl J Med (1974) 2.13
Regulation of mast cell survival by IgE. Immunity (2001) 2.11
Acquired cellular immunity: extracellular killing of Listeria monocytogenes by a product of immunologically activated macrophages. Cell Immunol (1974) 2.07
Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol (2000) 2.06
NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci U S A (1999) 2.00
Cost-effectiveness of treatment of early stage endometrial cancer. Gynecol Oncol (1999) 1.99
Recommended policies for uses of human tissue in research, education, and quality control. Ad Hoc Committee on Stored Tissue, College of American Pathologists. Arch Pathol Lab Med (1999) 1.96
CHO mutants resistant to colchicine, colcemid or griseofulvin have an altered beta-tubulin. Cell (1980) 1.88
Cutaneous basophil hypersensitivity. 3. Participation of the basophil in hypersensitivity to antigen-antibody complexes, delayed hypersensitivity and contact allergy. Passive transfer. J Immunol (1971) 1.84
Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Cancer Res (1984) 1.83
Discoidin I is implicated in cell-substratum attachment and ordered cell migration of Dictyostelium discoideum and resembles fibronectin. Cell (1984) 1.82
Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway. Oncogene (1999) 1.81
Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet (1994) 1.81
An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res (2000) 1.81
Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology (1997) 1.80
Evidence for a precursor of the high-affinity metastasis-associated murine laminin receptor. Biochemistry (1989) 1.80
Effects of transformation on fibronectin gene expression using cloned fibronectin cDNA. J Biol Chem (1981) 1.79
Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease. Neurogenetics (2006) 1.79
Human gene cloning: the storm before the lull? Nature (1986) 1.78
Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res (2001) 1.77
Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res (1988) 1.75
Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. J Exp Med (2001) 1.74
Secretion of leukotriene C and other arachidonic acid metabolites by macrophages challenged with immunoglobulin E immune complexes. J Exp Med (1982) 1.73
Communication skills training in oncology. Description and preliminary outcomes of workshops on breaking bad news and managing patient reactions to illness. Cancer (1999) 1.73
Elevation of multiple serum markers in patients with stage I ovarian cancer. J Natl Cancer Inst (1993) 1.71
Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. Circ Res (2000) 1.69
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med (1988) 1.67
BCG and cancer. N Engl J Med (1974) 1.66
A new pathway for protein export in Saccharomyces cerevisiae. J Cell Biol (1996) 1.66
Construction of a recombinant bacterial plasmid containing pro-alpha 1(I) collagen DNA sequences. J Biol Chem (1980) 1.65
Efflux of radiolabeled polyethylene glycols and albumin from rat brain. Am J Physiol (1981) 1.62
CA125 antigen levels in obstetric and gynecologic patients. Obstet Gynecol (1984) 1.61
High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol (1993) 1.61
Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet (2000) 1.61
Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J Natl Cancer Inst (1993) 1.60
Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. Am J Obstet Gynecol (1984) 1.60
Construction of a recombinant bacterial plasmid containing a chick pro-alpha2 collagen gene sequence. Proc Natl Acad Sci U S A (1978) 1.59
p53 overexpression in advanced-stage endometrial adenocarcinoma. Am J Obstet Gynecol (1996) 1.59
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction. Am J Obstet Gynecol (1990) 1.59
HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy. Oncogene (2006) 1.58
Role of laminin receptor in tumor cell migration. Cancer Res (1987) 1.58
PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics. Clin Cancer Res (1998) 1.58
Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol (1996) 1.58
Eukaryotic DNA methylation. Hum Genet (1983) 1.57
IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells. J Exp Med (1983) 1.56
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer (2009) 1.54
Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res (1991) 1.52
Diagnosis of genetic disease using recombinant DNA. Supplement. Hum Genet (1987) 1.50
Tumor promoters and Kirsten sarcoma virus increase synthesis of a secreted glycoprotein by regulating levels of translatable mRNA. Cell (1980) 1.50
Snoring and nocturnal oxygen desaturations in an Italian middle-aged male population. Epidemiologic study with an ambulatory device. Chest (1994) 1.50